NEMAURA MED INC's ticker is NMRD and the CUSIP is 640442208. A total of 19 filers reported holding NEMAURA MED INC in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,422 | -65.9% | 26,737 | 0.0% | 0.00% | – |
Q2 2023 | $24,734 | +3.4% | 26,737 | 0.0% | 0.00% | – |
Q1 2023 | $23,930 | -22.4% | 26,737 | +48.9% | 0.00% | – |
Q4 2022 | $30,824 | -16.7% | 17,951 | 0.0% | 0.00% | – |
Q3 2022 | $37,000 | -19.6% | 17,951 | 0.0% | 0.00% | – |
Q2 2022 | $46,000 | -41.0% | 17,951 | 0.0% | 0.00% | – |
Q1 2022 | $78,000 | -4.9% | 17,951 | 0.0% | 0.00% | – |
Q4 2021 | $82,000 | -24.1% | 17,951 | 0.0% | 0.00% | – |
Q3 2021 | $108,000 | -41.9% | 17,951 | 0.0% | 0.00% | – |
Q2 2021 | $186,000 | -71.0% | 17,951 | -78.6% | 0.00% | – |
Q1 2021 | $641,000 | +106.1% | 83,841 | +1.7% | 0.00% | – |
Q4 2020 | $311,000 | +7.2% | 82,442 | +0.9% | 0.00% | – |
Q3 2020 | $290,000 | -58.9% | 81,683 | +7.1% | 0.00% | – |
Q2 2020 | $705,000 | – | 76,255 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alyeska Investment Group, L.P. | 1,842,565 | $580,408 | 0.00% |
VANGUARD GROUP INC | 126,682 | $39,905 | 0.00% |
UBS Group AG | 85 | $27 | 0.00% |
NewEdge Advisors, LLC | 360 | $113 | 0.00% |
OSAIC HOLDINGS, INC. | 500 | $158 | 0.00% |
HAZLETT, BURT & WATSON, INC. | 30 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 4,158 | $1,310 | 0.00% |
NORTHERN TRUST CORP | 26,737 | $8,422 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 107,897 | $34,829 | 0.00% |